Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 7, 2009
Human Molecular Genetics 2009 18(19):3594-3604; doi:10.1093/hmg/ddp307
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/19/3594    most recent
ddp307v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Watson, J. A.
Right arrow Articles by McCann, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, J. A.
Right arrow Articles by McCann, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Generation of an epigenetic signature by chronic hypoxia in prostate cells

Jenny A. Watson1,*, Chris J. Watson1, Ann-Maria McCrohan1, Kathryn Woodfine2, Miriam Tosetto3, Jennifer McDaid4, Emma Gallagher1, David Betts4, John Baugh1, Jacintha O'Sullivan3, Adele Murrell2, R. William G. Watson1 and Amanda McCann1

1 The UCD School of Medicine and Medical Science and The UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland, 2 Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, UK, 3 Centre for Colorectal Disease, Education and Research Centre, St Vincents University Hospital (SVUH), Elm Park, Dublin 4, Ireland and 4 National Centre for Medical Genetics, Our Lady's Children's Hospital, Crumlin, Dublin 12, Ireland

* To whom correspondence should be addressed. Tel: +353 17166742; Fax: +353 17166888; Email: jennywatson2008{at}gmail.com

Received May 21, 2009; Accepted July 1, 2009

Increasing levels of tissue hypoxia have been reported as a natural feature of the aging prostate gland and may be a risk factor for the development of prostate cancer. In this study, we have used PwR-1E benign prostate epithelial cells and an equivalently aged hypoxia-adapted PwR-1E sub-line to identify phenotypic and epigenetic consequences of chronic hypoxia in prostate cells. We have identified a significantly altered cellular phenotype in response to chronic hypoxia as characterized by increased receptor-mediated apoptotic resistance, the induction of cellular senescence, increased invasion and the increased secretion of IL-1β, IL6, IL8 and TNF{alpha} cytokines. In association with these phenotypic changes and the absence of HIF-1{alpha} protein expression, we have demonstrated significant increases in global levels of DNA methylation and H3K9 histone acetylation in these cells, concomitant with the increased expression of DNA methyltransferase DMNT3b and gene-specific changes in DNA methylation at key imprinting loci. In conclusion, we have demonstrated a genome-wide adjustment of DNA methylation and histone acetylation under chronic hypoxic conditions in the prostate. These epigenetic signatures may represent an additional mechanism to promote and maintain a hypoxic-adapted cellular phenotype with a potential role in tumour development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.